PRECISION OPTICS CORPORATION, INC. Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)
PRECISION OPTICS CORPORATION, INC. (POCI) reported Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) of $61.20 thousand for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Notes › and Others › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease · last filed 2026-05-13
- PRECISION OPTICS CORPORATION, INC. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2026-03-31 was $39.91K.
- PRECISION OPTICS CORPORATION, INC. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2025-12-31 was $37.68K, a 43.17% increase year-over-year.
- PRECISION OPTICS CORPORATION, INC. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2025-09-30 was -$16.39K.
- PRECISION OPTICS CORPORATION, INC. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2025-03-31 was -$62.71K, a 217.92% decline year-over-year.
| Period end | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 3 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 6 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 9 month |
|---|---|---|---|
| 2026-03-31 | $39.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $77.59K derived: sum of 2 quarters · filed 2026-05-13 | $61.20K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $37.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17 | $21.29K 10-Q · filed 2026-02-17 | |
| 2025-09-30 | -$16.39K 10-Q · filed 2025-11-13 | ||
| 2025-03-31 | -$62.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$36.39K derived: sum of 2 quarters · filed 2026-05-13 | -$52.04K 10-Q · filed 2026-05-13 |
| 2024-12-31 | $26.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17 | $10.67K 10-Q · filed 2026-02-17 | |
| 2024-09-30 | -$15.65K 10-Q · filed 2025-11-13 | ||
| 2024-03-31 | $53.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-15 | $219.72K 10-Q · filed 2025-05-15 | |
| 2023-12-31 | $166.54K 10-Q · filed 2025-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |